Learn more

SOFAR SPA

Overview
  • Total Patents
    163
  • GoodIP Patent Rank
    11,317
  • Filing trend
    ⇩ 62.0%
About

SOFAR SPA has a total of 163 patent applications. It decreased the IP activity by 62.0%. Its first patent ever was published in 1991. It filed its patents most often in WIPO (World Intellectual Property Organization), Italy and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, foods and drinks and biotechnology are PERFORMANCE LABS PTE LTD, CERECIN INC and JIANGXI YIBAINIAN PHARMACEUTICAL CO LTD.

Patent filings per year

Chart showing SOFAR SPAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Biffi Andrea 90
#2 Fiore Walter 60
#3 Rossi Ruggero 54
#4 Guglielmetti Simone Domenico 31
#5 Labruzzo Carla 25
#6 Andrea Biffi 14
#7 Walter Fiore 11
#8 Ruggero Rossi 10
#9 Salamina Silvia 9
#10 Balzaretti Silvia 8

Latest patents

Publication Filing date Title
AU2020260470A1 Method for evaluating the effects of a composition comprising microorganisms on intestinal microbiota
WO2020250209A2 Lactoferrin for oral use with antiviral action
WO2021053641A2 Compositions based on bacterial strains and berry extracts and their use as anti-inflammatories
WO2021053639A1 Bacterial strains, their compositions and their use for the treatment of gastrointestinal disorders
WO2021053642A1 Compositions based on bacterial strains and their use as anti-inflammatories
WO2021053636A1 Bacterial strains, their compositions and their use for the treatment of gastrointestinal disorders
WO2021005529A1 Bifidobacterium bifidum bacterial strain, the compositions thereof and related uses
WO2020245784A1 Composition for use in a method for prevention or treatment of maltnutrition in a subject suffering from a chronic inflammatory bowel diseases
WO2020084589A1 Bacterial strains of the lactobacillus paracasei species for use, oral or topical, in the treatment of disorders of the female urogenital tract
WO2019111189A1 Composition based on probiotics and uses thereof
CA3075235A1 New use for treatment of clostridium difficile infections
IT201800007928A1 Composition containing a mucolytic agent for the treatment of mucus hypersecretion and a device for its dosage
IT201800007527A1 Composition containing beclomethasone for the prevention and treatment of bacterial prostatitis and vaginitis
AU2017377139A1 Probiotics for use in the treatment of diverticulosis and diverticular disease
AU2017367302A1 Exopolysaccharides and uses thereof
CN109310719A The new medical application of probiotics
CN110191647A Prebiotics are used to improve the purposes of protein adsorption
WO2017195182A1 Use of probiotics for improving protein absorption
WO2017175123A1 Process for mesalazine solid formulations
IT201600122310A1 Composition for use in the treatment of bowel disorders